within Pharmacolibrary.Drugs.ATC.H;

model H04AA02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.2333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 0.6 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00011999999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H04AA02</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dasiglucagon is a glucagon analog used for the treatment of severe hypoglycemia in patients with diabetes mellitus. It is a stable formulation of glucagon, suitable for subcutaneous administration, and is approved for use in both adults and children aged 6 and above for emergency treatment of severe hypoglycemic episodes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects following a single subcutaneous administration.</p><h4>References</h4><ol><li><p>Xu, B, et al., &amp; Chen, Z (2021). Dasiglucagon: an effective medicine for severe hypoglycemia. <i>European journal of clinical pharmacology</i> 77(12) 1783–1790. DOI:<a href=&quot;https://doi.org/10.1007/s00228-021-03183-0&quot;>10.1007/s00228-021-03183-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34223944/&quot;>https://pubmed.ncbi.nlm.nih.gov/34223944</a></p></li><li><p> (2021). Dasiglucagon (Zegalogue) for severe hypoglycemia. <i>The Medical letter on drugs and therapeutics</i> 63(1631) 132–134. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34544102/&quot;>https://pubmed.ncbi.nlm.nih.gov/34544102</a></p></li><li><p>Tehranchi, R, et al., &amp; Maarbjerg, SJ (2022). Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study. <i>Current therapeutic research, clinical and experimental</i> 96 100668–None. DOI:<a href=&quot;https://doi.org/10.1016/j.curtheres.2022.100668&quot;>10.1016/j.curtheres.2022.100668</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35464292/&quot;>https://pubmed.ncbi.nlm.nih.gov/35464292</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H04AA02;
